Pay in 4 interest-free payments of $60.62 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
PubMed PMID: 26798350
Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells
is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme
CPI-169 was subcutaneously (SC) dosed to mice bearing KARPAS-422 subcutaneous xenografts at 200 mg/kg twice per day
SIB-1553A Catalog No.:M13931-10 PubMed PMID: 26798350SIB 1553A is an orally bioavailable nicotinic acetylcholine receptors (nAChRs) agonist, with selectivity for 4 subunit containing nAChRs. SIB 1553A is also a selective neuronal nAChR ligand. SIB 1553A is a cognitive enhancer, and has therapeutic potential for the symptomatic treatment of Alzheimers disease and other cognitive disorders. Product information CAS Number: 191611 89 9 Molecular Weight: 273. 82 Formula: C13H20ClNOS Chemical Name: 4 {[2 (1